Overview
What is Commonwealth Cancer Consortium Inc?
The Commonwealth Cancer Consortium Inc is a Boston-based nonprofit organization dedicated to advancing cancer research and finding cures for some of the most complex and challenging diseases. They collaborate with five top cancer research centers, including Dana-Farber Cancer Institute, the Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Massachusetts Institute of Technology's Koch Institute for Integrative Cancer Research, the University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. Their mission is to support multidisciplinary research teams, focusing on diagnosing, treating, and ideally curing difficult-to-treat cancers. With a team of 14 dedicated individuals, they aim to make a significant impact in the field of cancer research and provide hope for patients and their families.
Official website here: www.breakthroughcancer.org
What are the reviews and ratings of this charity?
Commonwealth Cancer Consortium Inc is not currently rated by Charity Navigator because it lacks necessary data for an evaluation. Specifically, an Accountability & Finance or Impact & Measurement beacon score is required. The absence of a rating is not indicative of the organization's performance but reflects the insufficiency of available data.
Despite the lack of a formal rating, available information indicates that Commonwealth Cancer Consortium Inc. operates independently and receives significant support from the public or governmental units. However, only two years of electronically-filed IRS Form 990 are available, which restricts a full evaluation of their financial accountability and transparency.
Currently, there is no user feedback available from GreatNonprofits, so public sentiment cannot be gauged at this time. Additional data is needed for a comprehensive evaluation of the organization's impact, community engagement, leadership, and adaptability strategies.
This AI summary has been generated from information found on Charity Navigator.
Is Commonwealth Cancer Consortium Inc legitimate?
Commonwealth Cancer Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Commonwealth Cancer Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $1,280,731
Professional Fundraising Fees: $0
Other Salaries and Wages: $765,845
For more financial information, click here
Official website here: www.breakthroughcancer.org
What is the mission statement of Commonwealth Cancer Consortium Inc?
The Commonwealth Cancer Consortium Inc is a foundation dedicated to advancing translational research in some of the most challenging to treat cancers. With partner organizations that are leading cancer research centers, the consortium brings together brilliant and creative minds in the country. They embrace a scientific movement that accepts nothing less than multidisciplinary collaboration in patient-centric cancer research. Working closely with teams of scientists, engineers, and clinical researchers, they focus on diagnosing, treating, and ideally curing intractable forms of cancer. Despite advancements in research and technology, many patients have been left behind, and there are cancers where progress remains stagnant. The Commonwealth Cancer Consortium is committed to making headway in these complex and challenging diseases and finding hope for patients and their families.
Official website here: www.breakthroughcancer.org
Who is the CEO of Commonwealth Cancer Consortium Inc?
William Hulme is the Director of Commonwealth Cancer Consortium Inc.
Official website here: www.breakthroughcancer.org
What is the revenue of Commonwealth Cancer Consortium Inc?
Commonwealth Cancer Consortium Inc's revenue in 2022 was $27,161,244.
Official website here: www.breakthroughcancer.org
Who are the executives of Commonwealth Cancer Consortium Inc and what are their salaries?
The average compensation at Commonwealth Cancer Consortium Inc during 2022 was $146,184. There are 14 employees and 13 volunteers at Commonwealth Cancer Consortium Inc.
Here are 19 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $255,235
- Related: $0
- Other: $39,083
- Compensation: $201,275
- Related: $0
- Other: $10,738
- Compensation: $250,000
- Related: $0
- Other: $13,190
- Compensation: $240,482
- Related: $0
- Other: $38,482
- Compensation: $187,913
- Related: $0
- Other: $28,204
- Compensation: $145,826
- Related: $0
- Other: $16,954
Official website here: www.breakthroughcancer.org
Where can I find the form 990 for Commonwealth Cancer Consortium Inc?
Commonwealth Cancer Consortium Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.breakthroughcancer.org
Learn more at the official website: www.breakthroughcancer.org
Mission Statement of Commonwealth Cancer Consortium Inc
Commonwealth Cancer Consortium Inc, a foundation dedicated to making a significant impact on some of the most challenging and complex cancers, believes in the power of collaboration and the importance of translational research. With a mission that accepts nothing less than multi-institutional collaboration in patient-centric cancer research, this organization brings together some of the most brilliant and creative minds from top cancer research centers across the country.
The foundation is committed to staying at the forefront of scientific advancements in diagnosing, treating, and ideally curing cancers that have left many patients behind. While advancements in research and technology have benefited many, there are still too many cancers where the needle remains unmoved. Break Through Cancer, as the organization is called, is determined to make headway in these intricate and difficult diseases and to provide hope for patients and their families.
Working closely with teams of scientists, engineers, and clinical researchers, Commonwealth Cancer Consortium Inc focuses its efforts on the most difficult to treat cancers. The foundation's vision is rooted in the belief that by combining resources, knowledge, and expertise, they can make a real difference in the lives of those affected by these complex diseases. Through their unwavering commitment to patient-centric research and collaboration, Commonwealth Cancer Consortium Inc continues to push the boundaries of what is possible in the fight against cancer.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Commonwealth Cancer Consortium Inc significantly impacts the landscape of cancer research by spearheading innovative initiatives aimed at tackling some of the most challenging and difficult-to-treat cancers. By fostering collaboration among leading cancer research centers, including Dana-Farber Cancer Institute, John Hopkins, MIT's Koch Institute, MD Anderson, and Memorial Sloan Kettering, the Consortium brings together a collective pool of brilliant minds dedicated to transformative research.
The Consortium's focus on translational research aims to intercept cancer at its earliest stages, develop more effective treatments, and accelerate the quest for cures for the deadliest types of cancer. This approach not only enhances the scientific community's ability to address complex diseases but also prioritizes patient-centric research, ensuring that the needs and experiences of patients remain at the forefront.
Through its funding efforts, Commonwealth Cancer Consortium Inc empowers teams of researchers to push the boundaries of existing knowledge and technology. This commitment is crucial, as many patients still face unmet needs in cancer treatment, with numerous cancers showing limited progress over the years. By addressing these gaps, the Consortium strives to provide hope and improved outcomes for patients and their families, marking a vital advancement in the fight against cancer.
This information is meant to be a general summary of Commonwealth Cancer Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $3,199
- Gross Receipts: $27,161,244
Assets and Liabilities:
- Total Assets: $102,328,231
- Total Liabilities: $1,254,932
- Net Assets: $101,073,299
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2020
Phone
(800) 757-9881Principal Officer
William Hulme
Main Address
101 ROGERS STREET, CAMBRIDGE, MA, 02142
Website
www.breakthroughcancer.orgIf you are a representative of Commonwealth Cancer Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.